Patents Assigned to Beijing Jiankai Technology Co., Ltd.
  • Patent number: 8003089
    Abstract: The present invention relates to Y-shape branched PEG derivatives of formulae (I) to (IV). The present invention also relates to conjugates of these Y-shape derivatives and drug molecules, pharmaceutical compositions comprising those conjugates.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: August 23, 2011
    Assignee: Beijing Jiankai Technology Co., Ltd.
    Inventors: Shishan Ji, Dequan Zhu
  • Patent number: 7708978
    Abstract: The present invention relates to an active targeted water-solubility macromolecule polymer, conjugate with interferon and pharmaceutical composition comprising the conjugate. The targeted agent includes, for example, glucose, galatose and the like, as well as their derivates. The conjugate of the present invention is well in water-solubility and have long physiological cycle half-life period, and have specific recognition to pathology organize, improved and increased medication effect of interferon to Hepatitis B, Hepatitis C etc. infectivity sickness and cancer, infect complication etc.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: May 4, 2010
    Assignee: Beijing Jiankai Technology Co., Ltd.
    Inventors: Shishan Ji, Dequan Zhu
  • Publication number: 20050220753
    Abstract: The present invention discloses conjugates of polyethylene glycol and flavone or flavonoid drugs. The conjugates are formed by attaching PEG to the flavone derivatives such as puerarin, daidzein, baicalein and baicalin to improve their water solubility and circulation half-lives in the body. Because PEG is non-toxic and non-immunogenic, PEG conjugated drug molecules will have better therapeutic effects and convenience in administration.
    Type: Application
    Filed: March 20, 2003
    Publication date: October 6, 2005
    Applicant: BEIJING JIANKAI TECHNOLOGY CO., LTD
    Inventors: Shishan Ji, Dequan Zhu